APA

Fox E., Levin K., Zhu Y., Segers B., Balamuth N., Womer R., Bagatell R. & Balis F. (20190920). Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin. : The oncologist.

Chicago

Fox Elizabeth, Levin Kristin, Zhu Yan, Segers Blair, Balamuth Naomi, Womer Richard, Bagatell Rochelle and Balis Frank. 20190920. Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin. : The oncologist.

Harvard

Fox E., Levin K., Zhu Y., Segers B., Balamuth N., Womer R., Bagatell R. and Balis F. (20190920). Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin. : The oncologist.

MLA

Fox Elizabeth, Levin Kristin, Zhu Yan, Segers Blair, Balamuth Naomi, Womer Richard, Bagatell Rochelle and Balis Frank. Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin. : The oncologist. 20190920.